Latest AI and machine learning research in oncology/hematology for healthcare professionals.
PURPOSE: To develop and validate an AI method for automated quantification of whole-skeleton bone marrow (BM) metabolic activity using Carbon 11 (11C)-methionine (MET) PET/CT and to evaluate its prognostic value compared with Fluorine 18 (18F)-fluorodeoxyglucose (FDG) PET/CT in patients with newly diagnosed MM. METHODS: This prospective study included 49 patients (median age, 68 years; 29 males) w...
While the concept of predictive imaging is not entirely new, advanced analytic tools such as radiomics and machine learning have laid the foundation for a new generation of predictive imaging, which goes far beyond what is visible to the human eye. Predictive imaging has emerged as a transformative tool in abdominal oncology, offering the potential to personalize cancer detection and diagnosis, st...
Classifying cancer subtypes is crucial for clinical diagnosis and therapy. Recently, graph neural network (GNN)-based methods have been explored for t...
OBJECTIVE: This study aims to develop and validate an integrated multi-task framework for hepatocellular carcinoma analysis by combining deep learning...
Early detection of neuroendocrine tumors (NETs) is crucial for early and effective intervention, thus reducing the likelihood of tumor progression and...
Globally, breast cancer represents the leading cancer type, with millions of women impacted annually. The success of breast cancer treatment relies he...
Cervical cancer remains a major cause of mortality among women worldwide, highlighting the need for advances in diagnostic and therapeutic strategies....
BACKGROUND: Chronic limb-threatening ischemia (CLTI), the most severe form of peripheral artery disease, is associated with a high risk of limb loss. ...
Accurate brain tumor segmentation plays a pivotal role in clinical decision-making, providing essential support for disease screening, treatment plann...
OBJECTIVES: Given its high global mortality rate, pancreatic ductal adenocarcinoma (PDAC) remains a significant area of investigation. However, a robu...
Artificial intelligence (AI) has emerged as a transformative tool across the various domains of head and neck oncology. From early screening and risk ...
The high heterogeneity of Hepatocellular Carcinoma (HCC) severely hampers clinical outcomes. Current classifications based on gene expression profiles...
INTRODUCTION: Acute lymphoblastic leukemia (ALL) is a highly heterogeneous hematologic malignancy with poor prognosis in refractory and relapsed cases...
BACKGROUND: Colony-stimulating factor-1 receptor (CSF1R) signaling is crucial for the ability of tumor-associated macrophages (TAMs) to establish an i...
PURPOSE: Triple-negative breast cancer (TNBC) is an aggressive subtype of breast cancer with limited treatment options and poorer overall survival tha...
PURPOSE: NHOC and NHOP, defined as the normalized distances from peak uptake to tumour centroid and perimeter, are novel PET/CT metrics of tumour aggr...
BACKGROUND: Early and late hepatocellular carcinoma (HCC) recurrences, which are driven by residual and de novo tumors, respectively, differ in biolog...
Magnetic hyperthermia offers targeted cancer therapy using alternating magnetic fields (AMFs) to heat nanoparticles. This study evaluates graphene-mag...
BACKGROUND AND OBJECTIVE: Multimodal artificial intelligence (AI) algorithms have been validated to predict prostate cancer (PCa) metastasis using com...
Lung cancer is one of the leading causes of cancer-related mortality globally, primarily due to the high frequency of late-stage diagnoses. While exis...